National Institutes of Health–Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities

Eight manufacturing facilities participating in the National Institutes of Health–sponsored Clinical Islet Transplantation (CIT) Consortium jointly developed and implemented a harmonized process for the manufacture of allogeneic purified human pancreatic islet (PHPI) product evaluated in a phase 3 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricordi, Camillo, Goldstein, Julia S., Balamurugan, A.N., Szot, Gregory L., Kin, Tatsuya, Liu, Chengyang, Czarniecki, Christine W., Barbaro, Barbara, Bridges, Nancy D., Cano, Jose, Clarke, William R., Eggerman, Thomas L., Hunsicker, Lawrence G., Kaufman, Dixon B., Khan, Aisha, Lafontant, David-Erick, Linetsky, Elina, Luo, Xunrong, Markmann, James F., Naji, Ali, Korsgren, Olle, Oberholzer, Jose, Turgeon, Nicole A., Brandhorst, Daniel, Chen, Xiaojuan, Friberg, Andrew S., Lei, Ji, Wang, Ling-jia, Wilhelm, Joshua J., Willits, Jamie, Zhang, Xiaomin, Hering, Bernhard J., Posselt, Andrew M., Stock, Peter G., Shapiro, A.M. James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2016
Materias:
Islet Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079635/
https://www.ncbi.nlm.nih.gov/pubmed/27465220
http://dx.doi.org/10.2337/db16-0234

Ejemplares similares

Ejemplares similares